M&R Capital Management’s Boston Scientific BSX Stock Holding History

M&R Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-17	Closed	–	–	552
2016 Q4	$0	Hold	17	–	–	﹤0.01%	553
2016 Q3	$0	Buy	+17	New	+$406	﹤0.01%	542

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

M&R Capital Management's BSX Position: Q1 2017 in Review

M&R Capital Management sold out of Boston Scientific (BSX) in Q1 2017, closing a stake of 17 shares.

M&R Capital Management first reported a position in BSX in Q3 2016 and held it in 2 quarters. The position peaked at $0 in Q4 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

M&R Capital Management reported no remaining Boston Scientific position as of Q1 2017 after selling out during the quarter.
M&R Capital Management sold 17 Boston Scientific shares in Q1 2017.
M&R Capital Management first reported a position in Boston Scientific in Q3 2016 and held it in 2 quarters.
M&R Capital Management's Boston Scientific position peaked at $0 in Q4 2016.
552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on M&R Capital Management's 13F filing for Q1 2017, filed 15 May 2017.